These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23899887)

  • 1. Myocardial dimensions and hemodynamics during 24-h ultraendurance ergometry.
    Pokan R; Ocenasek H; Hochgatterer R; Miehl M; Vonbank K; Von Duvillard SP; Franklin B; Würth S; Volf I; Wonisch M; Hofmann P
    Med Sci Sports Exerc; 2014 Feb; 46(2):268-75. PubMed ID: 23899887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair.
    Norozi K; Buchhorn R; Kaiser C; Hess G; Grunewald RW; Binder L; Wessel A
    Chest; 2005 Oct; 128(4):2563-70. PubMed ID: 16236924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interface of hypothalamic-pituitary-adrenocortical axis and circulating brain natriuretic peptide in prediction of cardiopulmonary performance during physical stress.
    Popovic D; Popovic B; Plecas-Solarovic B; Pešić V; Markovic V; Stojiljkovic S; Vukcevic V; Petrovic I; Banovic M; Petrovic M; Vujisic-Tesic B; Ostojic MC; Ristic A; Damjanovic SS
    Peptides; 2013 Sep; 47():85-93. PubMed ID: 23876603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.
    Berent R; von Duvillard SP; Crouse SF; Auer J; Green JS; Sinzinger H; Schmid P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):603-8. PubMed ID: 19494782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-flow severe aortic stenosis with preserved ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiovascular remodeling.
    Mizia-Stec K; Adamczyk T; Mizia M; Haberka M; Gasior Z; Trusz-Gluza M; Tendera M
    J Heart Valve Dis; 2011 May; 20(3):301-10. PubMed ID: 21714421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes.
    Vidotto C; Tschan H; Atamaniuk J; Pokan R; Bachl N; Müller MM
    Int J Sports Med; 2005 Oct; 26(8):645-50. PubMed ID: 16158369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers.
    Knebel F; Schimke I; Schroeckh S; Peters H; Eddicks S; Schattke S; Brechtel L; Lock J; Wernecke KD; Dreger H; Grubitz S; Schmidt J; Baumann G; Borges AC
    J Am Soc Echocardiogr; 2009 Jul; 22(7):803-9. PubMed ID: 19505796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure.
    Gundogdu F; Bozkurt E; Kiziltunc A; Sevimli S; Arslan S; Gurlertop Y; Senocak H; Karakelleoglu S
    Echocardiography; 2007 Feb; 24(2):113-7. PubMed ID: 17313541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological markers of cardiac damage are not related to measures of cardiac systolic and diastolic function using cardiovascular magnetic resonance and echocardiography after an acute bout of prolonged endurance exercise.
    Wilson M; O'Hanlon R; Prasad S; Oxborough D; Godfrey R; Alpendurada F; Smith G; Wong J; Basavarajaiah S; Sharma S; Nevill A; Gaze D; George K; Whyte G
    Br J Sports Med; 2011 Aug; 45(10):780-4. PubMed ID: 19854761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and cardiac cycle efficiency in cardiac surgery.
    Scolletta S; Ranaldi G; Carlucci F; Franchi F; Romano SM; Biagioli B
    Biomed Pharmacother; 2010 Oct; 64(8):511-5. PubMed ID: 20137881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late cardiovascular drift observable during ultraendurance exercise.
    Mattsson CM; Ståhlberg M; Larsen FJ; Braunschweig F; Ekblom B
    Med Sci Sports Exerc; 2011 Jul; 43(7):1162-8. PubMed ID: 21131858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.
    Staub D; Jonas N; Zellweger MJ; Nusbaumer C; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.